Biotech · Private company · Cambridge, MA, US
VBI Vaccines Inc
SEC CIK 0000764195
Track this companyFree. Adds VBI Vaccines Inc to your Dealase workspace and tells you when its record changes.
Clinical trials40 recruiting or active
Pipeline programs5From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline5
- Hepatitis B VaccinationPhase 3 · Hepatitis B VaccinesClinicalTrials.gov · fetched Nov 12, 2026
- CarmustinePhase 2 · Glioblastoma MultiformeClinicalTrials.gov · fetched Nov 12, 2026
- LomustinePhase 2 · Glioblastoma MultiformeClinicalTrials.gov · fetched Nov 12, 2026
- VBI-1901Phase 2 · Glioblastoma MultiformeClinicalTrials.gov · fetched Nov 12, 2026
- Data collectionVaccine Exposure During PregnancyClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials4
- PREHEVBRIO Pregnancy Outcomes RegistryWITHDRAWN · started Nov 30, 2023ClinicalTrials.gov NCT06097312 · fetched Nov 12, 2026
- Lot-to-lot Consistency of Sci-B-Vac™ in AdultsPHASE3 · COMPLETED · started Dec 14, 2017ClinicalTrials.gov NCT03408730 · fetched Nov 12, 2026
- Immunogenicity and Safety of Sci-B-Vac® to Engerix-B® in AdultsPHASE3 · COMPLETED · started Dec 13, 2017ClinicalTrials.gov NCT03393754 · fetched Nov 12, 2026
- Study to Evaluate Safety, Tolerability, and Optimal Dose of Candidate GBM Vaccine VBI-1901 in Recurrent GBM SubjectsPHASE1_PHASE2 · TERMINATED · started Dec 6, 2017ClinicalTrials.gov NCT03382977 · fetched Nov 12, 2026